Sartorius Stedim Biotech Liquidity Contract Review

Sartorius Stedim Biotech announced the results of its liquidity contract managed by Kepler Cheuvreux for the six months ending December 31, 2025. As of that date, the liquidity account held 32,966 shares and a cash balance of €6,457,086.94. The six-month period saw 5,079 buy transactions and 4,845 sell transactions, representing respective volumes of 272,457 shares for €51,769,936.60 and 275,047 shares for €52,809,559.69.

Comparatively, as of June 30, 2025, the account held 35,556 securities and €5,371,198.80 in cash, with a higher trading volume. The contract was established in accordance with AMF Decision No. 2021-01, which governs these accepted market practices.